Journal articles
Bispecific mAb(2) Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab
Stadlbauer K, Andorfer P, Stadlmayr G, Ruker F, Wozniak-Knopp G. Bispecific mAb(2) Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab. International Journal of Molecular Sciences. 2022;23(9). doi:https://doi.org/10.3390/ijms23095208
external links and characteristics of the publication:
BOKU Autors
Florian Rüker
Ao.Univ.-Prof.i.R. Dipl.-Ing.Dr.nat.techn. Florian Rüker
Gerhard Stadlmayr
Dipl.-Ing.Dr. Gerhard Stadlmayr
Gordana Wozniak-Knopp
Dipl.-Biol. Dr.rer.nat. Gordana Wozniak-Knopp
Katharina Stadlbauer
Katharina Stadlbauer B.Sc.
Peter Michael Andorfer
Dr. Peter Michael Andorfer
